IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10335409 B1

PDFFull Text
Date of Patent:
Jul. 02, 2019

Filed:

Jun. 11, 2018

Inhibitors of hepatitis c virus

Applicant:

Gilead Pharmasset Llc, Foster City, CA (US);

Inventors:

Kyla Bjornson, San Lorenzo, CA (US);

Eda Canales, San Mateo, CA (US);

Jeromy J. Cottell, Redwood City, CA (US);

Kapil K. Karki, Foster City, CA (US);

Ashley A. Katana, North Olmsted, OH (US);

Darryl Kato, San Francisco, CA (US);

Tetsuya Kobayashi, Pleasanton, CA (US);

John O. Link, San Francisco, CA (US);

Ruben Martinez, San Diego, CA (US);

Barton W. Phillips, San Mateo, CA (US);

Hyung-jung Pyun, Fremont, CA (US);

Michael Sangi, San Mateo, CA (US);

Adam J. Schrier, Redwood City, CA (US);

Dustin Siegel, Half Moon Bay, CA (US);

James G. Taylor, Burlingame, CA (US);

Chinh V. Tran, San Diego, CA (US);

Teresa A. Trejo Martin, Belmont, CA (US);

Randall W. Vivian, San Mateo, CA (US);

Zheng-Yu Yang, Palo Alto, CA (US);

Jeff Zablocki, Los Altos, CA (US);

Sheila Zipfel, San Mateo, CA (US);

Assignee:

Gilead Pharmasset LLC, Foster City, CA (US);

Attorney:

Sheppard Mullin Richter & Hampton LLP

Primary Examiner:

Thomas S Heard

Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 31/498 (2006.01); C07D 498/16 (2006.01); A61K 31/4985 (2006.01); C07D 498/22 (2006.01); A61K 31/4745 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 45/06 (2006.01); C07K 5/087 (2006.01); C07K 5/08 (2006.01); C07K 5/083 (2006.01); A61K 38/21 (2006.01); A61K 38/06 (2006.01); A61K 31/10 (2006.01); A61K 31/401 (2006.01); C07D 241/36 (2006.01); C07D 403/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/498 (2013.01); A61K 31/10 (2013.01); A61K 31/401 (2013.01); A61K 31/4745 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 38/06 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); C07D 241/36 (2013.01); C07D 403/14 (2013.01); C07D 498/16 (2013.01); C07D 498/22 (2013.01); C07K 5/08 (2013.01); C07K 5/0808 (2013.01); C07K 5/0812 (2013.01); C07K 5/0827 (2013.01); A61K 38/00 (2013.01);
Abstract

Compounds of Formula I are disclosed As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.

Find Patent Forward Citations

Loading…